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A B S T R A C T
Objective: This study aimed to evaluate the cost-effectiveness of a group diabetes education program
delivered by health promoters in community health centers in the Western Cape, South Africa.
Methods: The effectiveness of the education program was derived from the outcomes of a pragmatic
cluster randomized controlled trial (RCT). Incremental operational costs of the intervention, as
implemented in the trial, were calculated. All these data were entered into a Markov micro-simulation
model to simulate clinical outcomes and health costs that were expressed as an Incremental Cost
Effectiveness Ratio (ICER).
Results: The only signiﬁcant effect from the RCT at one year was a reduction in blood pressure (systolic
blood pressure 4.65 mmHg (95%CI:918 to 012) and diastolic blood pressure 3.30 mmHg
(95%CI:535 to 126)). The ICER for the intervention, based on the assumption that the costs would
recur every year and the effect could be maintained, was 1862 $/QALY gained.
Conclusion: A structured group education program performed by mid-level trained healthcare workers
at community health centers, for the management of Type II diabetes in the Western Cape, South Africa is
therefore cost-effective.
Practice implications: This cost-effectiveness analysis supports the more widespread implementation of
this intervention in primary care within South Africa.
 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The burden of non-communicable chronic diseases is substan-
tial in low and middle-income countries and is predicted to
increase with improved life expectancy and changing lifestyle
associated with urbanization and exposure to energy dense
processed globalized foods [1]. Type II diabetes makes a signiﬁcant
and growing contribution to morbidity and mortality in South
Africa and is thought to affect 65% of the adult population
[2]. However recent studies have shown rates as high as 33% in
some communities in Cape Town [3]. Type II diabetes is the fourth
commonest condition seen in South African ambulatory primary* Corresponding author at: Division of Family Medicine and Primary Care,
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nd/4.0/).care and could have signiﬁcant economic consequences for poor
families as it often impacts working age people [4].
Effective management of type II diabetes requires medication as
well as self-care and lifestyle change from the patient [5]. To meet
the challenges of diabetes in primary care, we will have to
strengthen both pharmacological and educational interventions, as
well as long term continuity of care [6]. In our context most
patients are seen by nurses, with support from a doctor, and there
are few, if, any more specialized staff such as dieticians or
podiatrists. Although the technical quality of care has been slowly
improving from a low baseline, little attention has been given to a
structured and comprehensive education program [7]. Behavior
change counseling to promote self-care and lifestyle change has
not been done well in our setting because health workers are
disillusioned with the impact of their current health education,
lack knowledge about lifestyle modiﬁcation, have poor counseling
skills, and work with time pressure and a lack of physical space [8].
Group diabetes education has been shown to be effective in
more resource intensive settings in Europe and America whenarticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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systematic reviews however do not include trials from the African
context and only one previous study utilized lay counsellors,
similar to health promoters in our context, and was reported as
having a high risk of bias [9]. The study, which was based in the
USA, included only women, and had no effect on HbA1c or body
mass index at six months [9].
Given the situation outlined above a new approach to group
diabetes education was developed and implemented in commu-
nity health centers in Cape Town [10]. This education program,
which is described more fully below, has been evaluated by means
of a pragmatic cluster randomized controlled trial and found to
have a signiﬁcant effect on blood pressure after one year [11]. The
other outcomes measured, such as self-care activities, psychologi-
cal factors, clinical measurements, and quality of life showed no
signiﬁcant change [11]. However the wide-scale implementation
of appropriate models of behavior change counseling in our
context will depend on their cost-effectiveness. Although lifestyle
interventions for diabetes have been found to be cost-effective
in resource rich environments, few studies have looked at this in
resource constrained settings, such as South Africa [12]. The aim of
this study, therefore, was to determine the cost-effectiveness of
this group education program by calculating an incremental cost-
effectiveness ratio (ICER). The ICER is calculated by means of a
Markov micro-simulation model that predicts the increase in costs
incurred over time, as a result of the intervention, and compares
them with the predicted gains in quality adjusted life years
(QALYs). One QALY is the equivalent of one additional year of life
gained without illness.
2. Methods
The intervention was previously evaluated using a cluster
randomized trial design and the only signiﬁcant outcome (blood
pressure) was assessed and used in a cost-effectiveness prediction
model for cardiovascular disease, while taking into consideration
the cost of delivering the intervention. The model is based on the
Markov micro-simulation model, and evaluated the Incremental
Cost Effectiveness Ratio (ICER) and cost per Quality Adjusted Life
Years (QALY) saved.
The group education was designed to consist of four sessions
each lasting up to 60 min and was offered to all people with type II
diabetes attending 17 selected community health centers in the
Cape Town metropolitan area. These public sector services cater for
uninsured patients from low socio-economic groups who make up
the majority of the population in Cape Town and live in informal
settlements (shacks) or low cost housing.
The sessions were delivered by health promoters who have
secondary school education and had been recruited from the local
communities and trained over many years by the department of
health. The four sessions focused on: what is diabetes, lifestyle
modiﬁcation, understanding the medication, and avoiding com-
plications. Lifestyle modiﬁcation focused on healthy eating (choice
of food, portion size, approaches to cooking, timing of meals),
physical activity, foot care, tobacco smoking, alcohol use, and effect
of psychosocial stress. Each session was designed to be delivered in
a guiding style that was derived from motivational interviewing
[13]. This style was characterized by a collaborative approach that
evoked ideas and solutions from the patients, respected their
choices and sense of control, while attempting to empathically
understand their perspective. The sessions were structured in a
way that encouraged an exchange of information while providing a
comprehensive and systematic approach to the topics. A number of
educational materials were developed to support the group
sessions including a ﬂipchart and various card games. Health
promoters were trained over six days, by a family physician expertin motivational interviewing and a nurse diabetes educator, and
their experiences have been documented elsewhere [14].
Patients were expected to attend the sessions on a monthly
basis and as far as possible they were scheduled for the dates on
which they had to return for consultation or collection of
medication. For patients that were working however attendance
would require them to take time off work as they usually sent other
family members to collect medication. Patients were reminded
about the sessions by bulk text message and usually lived within
ten kilometers of the health center.
The pragmatic clustered randomized controlled trial has been
described fully elsewhere and the results have been published
[10,11,15]. Readers are referred to these publications for a full
description. In summary the trial randomly allocated 34 commu-
nity health centers in the Cape Town metropole to be either
intervention or control sites. Intervention sites implemented the
group diabetes education as described above and control sites
continued with usual care. Patients with type II diabetes were then
recruited at each community health center and overall there were
710 patients in the intervention group and 860 patients in the
control group. Baseline data was collected prior to the educational
intervention and again a year later. Follow up data was obtained
from 391 patients in the intervention group and 475 in the control
group. The primary outcome measures were deﬁned as improved
diabetes self-care activities, ﬁve percent weight loss, and a one
percent reduction in HbA1c level. Secondary outcomes were
improved diabetes speciﬁc self-efﬁcacy, locus of control, mean
blood pressure, mean weight loss, mean waist circumference,
mean HbA1c, mean total cholesterol levels, and quality of life. The
only signiﬁcant effect from the RCT was a signiﬁcant reduction in
blood pressure at one year (systolic blood pressure 465 mmHg
(918 to 012) and diastolic blood pressure 33 mmHg (535
to 126)). Blood pressure was measured by a trained nurse, using
an Omron digital blood pressure machine and according to a
standardized operating procedure. There was no difference in the
use of antihypertensive medications between the intervention and
control groups. The decrease in blood pressure at one year was
thought to be of clinical signiﬁcance.
Data was collected from the ﬁnancial records of the RCT within
the Division of Family Medicine and Primary Care, Stellenbosch
University. Costs related to the research study and which would
not be part of implementing the educational program in normal
service delivery were excluded. Only incremental costs that would
add additional costs to what is already being paid for by the health
services were considered. Interviews were held with the health
promoters, facility managers, district level ﬁnancial ofﬁcers, and
managers to ensure no important costs were missed.
All numerical data were checked and captured on an Excel
spreadsheet and the various costs of the intervention calculated.
Data on cost was then entered into a cost-effectiveness model for
cardiovascular disease that had been created and updated at
Harvard University in collaboration with the Chronic Disease
Initiative for Africa (CDIA) in Cape Town [16]. The model is based
on the Markov micro-simulation model. The model as a whole was
developed using South African datasets and should therefore be a
valid model to apply again to this South African context.
The model evaluated the Incremental Cost Effectiveness Ratio
and cost per Quality Adjusted Life Years (QALY) saved. The
incremental cost-effectiveness ratio (ICER) is the ratio of the
incremental increase in costs, measured in US$, to the beneﬁts of a
therapeutic intervention, measured in QALYs saved. Costs included
both the cost of the intervention itself as well as any long term
healthcare costs incurred related to cardiovascular disease, in
particular stroke and ischemic heart disease. The WHO deﬁnes
ICER as ‘‘very cost-effective’’ if it is less than one times the per
capita Gross Domestic Product (GDP) or ‘‘cost-effective’’ if it is less
Table 1
Summary of the intervention costs for the entire study population.
Intervention cost Unit cost $* Units Total $*
Salary costs
Health promotion ofﬁcers 3.83 544 h 2082
Training costs
Health promotion ofﬁcers 3.83 816 h 3123
Trainer 1 (Family physician/MI expert) 39.44 48 h 1893
Trainer 2 (Nurse/diabetes educator) 10.87 48 h 522
Refreshments for training 207.17 6 1243
Training manuals 0.03 460 pages 12
Travel costs for training 0.08 2040 km 165
Education material costs
Printing ﬂipchart 4.76 17 charts 81
Binding of ﬂipcharts 0.90 17 charts 15
Food game cards 19.51 17 sets 332
True/false game cards 4.70 17 sets 80
Printing costs 0.03 16320 pages 441
Operational costs
SMS reminders (Bulk SMS) 0.03 4080 SMS 110
Patient costs
Loss of earnings 4.95 640 patients 3171
Travel costs per patient 0.81 6120 trips 4961
* Rand costs converted to US$ 13/2/14 at rate of 0.09$ to 1ZAR.
Table 2
Number of deaths prevented compared to no intervention.
Annual cost,
persistent
beneﬁt
One year cost,
persistent
beneﬁt
One year cost,
one year
beneﬁt
One year cost,
three year
declining beneﬁt
Total CVA 5481 5481 57 374
Total IHD 4215 4215 148 427
Table 3
Incremental Cost-effectiveness Ratios of different scenarios.
Incremental
cost($)
Incremental
utility (QALY)
ICER
($/QALY)
Annual cost, persistent beneﬁt 125 0.0673 1862
One year cost, persistent beneﬁt 398 0.0673 Dominant
One year cost, one year beneﬁt 4 0.0044 Dominant
One year cost, three year
declining beneﬁt
23 0.0095 Dominant
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for South Africa is $6003 [18].
The model incorporated all basic cardiovascular risk factors (age,
sex, smoking, diabetes, blood pressure, total cholesterol, or body
mass index (BMI)) and predicted future rates of angina, myocardial
infarction, stroke, and death for the simulated population. The model
allowed for use of total cholesterol, when laboratory tests were
available, or BMI when they were not. The model could therefore
predict the effect on future cardiovascular events of a change in one
of the risk factors, in this case a reduction in blood pressure.
The baseline data from the RCT, which measured the risk factor
proﬁle of the study population, was used to generate a theoretical
population of one million people with diabetes in the model. The
theoretical population was created to share the same risk factor
proﬁle as the study population, but increased size of the population
for model stability. The incremental costs of implementing the
intervention over a one year period were also entered into the
model. The model was then used to predict future mortality from
CVD events over ten years, 30 years and eventually until all
members of the cohort die. The model also computed future costs
related to the intervention and to the treatment of CVD events. The
model was then able to compare the results for a population with
no intervention vs. a population with the intervention from the
RCT that had the decreased BP. From this comparison the model
was able to determine the incremental costs and the QALYs saved
(utility) and to calculate the ICER.
Since the trial only lasted one year, we explored four different
scenarios for what might happen in subsequent years and
calculated results for each scenario:
1. The intervention is repeated each year and the beneﬁts persist
over time. This scenario is closest to how the intervention would
be rolled out in the health services and would be the result of
most interest to decision-makers.
2. The intervention is performed once and the beneﬁts only occur in
that year. This scenario looks at the effect of a once off
intervention, which could be anticipated to have minimal impact.
3. The intervention is performed once, but the beneﬁts persist
indeﬁnitely assuming the behaviors are fully adopted by the
patient population. This scenario is unlikely given the likelihood
of beneﬁts decreasing over time if not reinforced.
4. The intervention is performed once and the beneﬁts gradually
decrease over three years. This is a relatively real life scenario
should the education only be offered once to patients.
3. Results
Table 1 shows a summary of the intervention costs incurred in
implementing the educational program from the societal perspec-
tive, which includes health system incurred costs and direct costs
of patient time spent seeking the additional education from the
health promoters. The cost per patient based on this analysis is
approximately $22 per year.
Table 2 shows the number of deaths that should be prevented by
implementing the educational intervention based on the four different
scenarios in the cost-effectiveness model. The two scenarios that
assume a persistent beneﬁt for the intervention prevent the same
number of deaths from cerebrovascular accidents (CVA) and ischemic
heart disease (IHD). In the two scenarios where the effect is assumed to
persist beyond the ﬁrst year over 5481 fatal strokes and 4215 ischemic
related deaths are averted per million people. The scenarios that
assume a one year or gradually reducing three year beneﬁt predict that
a much smaller number of deaths would be prevented.
Table 3 shows the ICER for the four different scenarios based
on the incremental costs and deaths averted from CVA and IHD.In each scenario the ICER is for the intervention under different
assumptions, regarding the length of time the intervention is in
place and the effects of the intervention.
Table 3 presents an ICER of 1862 $/QALY gained for the ﬁrst
scenario and ﬁnds that the other three scenarios were dominant in
the sense that less money would be spent overall to produce a
beneﬁt in terms of QALYs gained. This means that although there
were intervention costs, the savings from reduction in future
medical expenses such as hospitalizations and secondary preven-
tion care led to a net reduction in expenditure. In the ﬁrst scenario
the additional QALYs gained come at a net increased cost, but still
well within acceptable costs for the South African context. The ﬁrst
scenario, however, is the most realistic as the health services
would expect the educational program to be offered on a
continuous basis if it was implemented.
4. Discussion and Conclusion
4.1. Discussion
This intervention, despite its effectiveness being limited to a
reduction in blood pressure, would be cost-effective if implemen-
ted in South Africa. There is currently no other local data available
with regards to the ICER of educational interventions to improve
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reviews of cost-effectiveness, mainly from studies in more
developed countries, have found intensive lifestyle interven-
tions, smoking cessation counseling and most diabetes educa-
tion to be cost-effective [12,19]. However the evidence from
developing countries is generally of poor quality and might not
be sufﬁcient to guide decision making by policy makers [20]. This
study therefore, from a developing country context, adds useful
new evidence.
Group based education for people with type II diabetes has been
shown effective at improving fasting blood glucose levels, glycated
hemoglobin, diabetes knowledge and reducing systolic blood
pressure levels, body weight, and the requirement for diabetes
medication [9]. It is possible therefore that group education could
be more effective in our context, maybe if offered by more qualiﬁed
professional counsellors, nurses or doctors, although these are a
scarce resource in our setting. Health promoters have a more
superﬁcial knowledge base, are not as respected in the community
and struggled to fully adopt the guiding style [14]. A qualitative
process evaluation of this intervention showed that the health
promoters also struggled to ﬁnd suitable space for the group
education in the health centers [14]. Health promoters and study
coordinators also had difﬁculties communicating with patients
regarding the dates and times of educational meetings or changes
in arrangements. Many patients came from poor communities and
had no landline or shared their cell phone with other family
members [15]. These factors may have been partly responsible for
poor attendance at the educational sessions and may have reduced
the effect in the RCT.
Nonetheless, our study showed that even with the beneﬁt of
the intervention on blood pressure alone, it is still cost-effective.
If other beneﬁts could be shown with minimal additional costs,
then our estimates would be conservative. This is consistent with
studies, which showed the cardiovascular beneﬁts in people with
diabetes primarily in those who had intensive blood pressure
control and with the most promising cost-effectiveness results of
387 £/QALY gained [21]. Reduction in blood pressure has been
suggested to be of greater beneﬁt than intensive glucose-
lowering, particularly in older people with type II diabetes
[22–24].
As with any model the results depend on the assumptions made
and the ability of the model to predict real life. The strength of this
model is that it is based on South African data and the mini-Markov
approach is particularly suited to modelling chronic disease. The
expected beneﬁt of an ongoing intervention is likely to attenuate
over time and this could have been taken more into account in
the ﬁrst scenario. Nevertheless the second and fourth scenarios,
which were based on a more limited duration of effect were also
cost-effective. Blood pressure was measured according to a best
practice standard operating procedure and the decrease was not
correlated with any change in prescribing and was derived from an
intention to treat analysis. It was however not possible to blind the
ﬁeldworkers to the intervention.
Alongside this approach to group education the researchers have
also been developing an approach to individual brief behavior
change counseling based on the ﬁve A’s (Ask, Alert, Assess, Assist
and Arrange) and a guiding style [25]. Our long term vision is for an
approach to diabetes education that is embedded in the organization
of primary care, offers a comprehensive and systematic under-
standing of the disease via group education and supplements this
where needed with individual brief behavior change counseling. In
the future it may also be possible to offer more targeted education
for different categories of patients, such as the newly diagnosed or
those starting insulin. It is hoped that future research can test a more
comprehensive approach to education that combines group and
individual counseling in primary care settings.4.2. Conclusion
Structured group education, offered by health promoters with a
guiding style, for patients with type II diabetes mellitus in the
public sector primary care facilities of the Western Cape represents
value for money.
4.3. Practice implications
This cost-effectiveness analysis supports the more widespread
implementation of this intervention in primary care within South
Africa. However attention must be given to improving the
effectiveness of the intervention further, in line with international
experience. If possible more highly trained health workers should
deliver the intervention and health centers should be better
designed to accommodate group education.
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